(6-156) Orforglipron: An Investigational Oral Non-Peptide Glucagon-Like Peptide-1 Receptor Agonist as a Treatment Option for Obesity and Type 2 Diabetes

Tuesday, December 9, 2025

10:45 AM - 11:45 AM

Location: Bayside A, Level 1

Pharmacy School: Southwestern Oklahoma State University College of Pharmacy
Pharmacy School Location: Oklahoma

Co-Author(s): Mason Mann, Kyle Lacy, Hannah Allen, Jeremy Johnson

Primary Author(s)

Amber L. Williamson, n/a

Student
Southwestern Oklahoma State University College of Pharmacy